DISPOSITION OF CEFOTAXIME AND ITS DESACETYL METABOLITE IN MORBIDLY OBESE MALE AND FEMALE SUBJECTS

被引:35
作者
YOST, RL [1 ]
DERENDORF, H [1 ]
机构
[1] UNIV FLORIDA,COLL PHARM,BOX J-4,GAINESVILLE,FL 32610
关键词
D O I
10.1097/00007691-198606000-00011
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:189 / 194
页数:6
相关论文
共 10 条
[1]   PHARMACOKINETICS OF DRUGS IN OBESITY [J].
ABERNETHY, DR ;
GREENBLATT, DJ .
CLINICAL PHARMACOKINETICS, 1982, 7 (02) :108-124
[2]  
ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39
[3]   ASSAY OF CEFOTAXIME BY HIGH-PRESSURE-LIQUID CHROMATOGRAPHY [J].
BERGAN, T ;
SOLBERG, R .
CHEMOTHERAPY, 1981, 27 (03) :155-165
[4]   CEFOTAXIME KINETICS AFTER MULTIPLE-DOSE INTRAMUSCULAR STUDY IN HEALTHY-VOLUNTEERS [J].
HARVENGT, C ;
WAUTERS, G ;
MEUNIER, H .
CHEMOTHERAPY, 1981, 27 (03) :173-178
[5]  
KEES F, 1981, ARZNEIMITTEL-FORSCH, V31-1, P362
[6]   HUMAN PHARMACOLOGY OF CEFOTAXIME (HR-756), A NEW CEPHALOSPORIN [J].
LUTHY, R ;
MUNCH, R ;
BLASER, J ;
BHEND, H ;
SIEGENTHALER, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (02) :127-133
[7]   CEFOTAXIME KINETICS AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION OF SINGLE AND MULTIPLE DOSES [J].
NEU, HC ;
ASWAPOKEE, P ;
FU, KP ;
HO, I ;
MATTHIJSSEN, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) :677-685
[8]  
STOKHOLM KH, 1980, INT J OBESITY, V4, P57
[9]   ACTIVITY OF THE CEFOTAXIME (HR756) DESACETYL METABOLITE COMPARED WITH THOSE OF CEFOTAXIME AND OTHER CEPHALOSPORINS [J].
WISE, R ;
WILLS, PJ ;
ANDREWS, JM ;
BEDFORD, KA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (01) :84-86
[10]   RAPID CHROMATOGRAPHIC DETERMINATION OF CEFOTAXIME AND ITS METABOLITE IN BIOLOGICAL-FLUIDS [J].
YOST, RL ;
DERENDORF, H .
JOURNAL OF CHROMATOGRAPHY, 1985, 341 (01) :131-138